Oldest pages

Showing below up to 50 results in range #1 to #50.

View (previous 50 | ) (20 | 50 | 100 | 250 | 500)

  1. Muscle-invasive Bladder Cancer (2017)‏‎ (08:31, 14 December 2021)
  2. Open Radical Prostatectomy‏‎ (08:57, 17 December 2021)
  3. Urothelial Cancer of the Prostate‏‎ (09:00, 17 December 2021)
  4. Unresectable Locally Advanced and Metastatic Bladder Cancer‏‎ (09:55, 17 December 2021)
  5. Segemental ureterectomy‏‎ (14:35, 17 December 2021)
  6. Non-Germ Cell Tumours & Tumours of the Testicular Adnexa‏‎ (10:44, 19 December 2021)
  7. Urethral Tumours‏‎ (10:58, 19 December 2021)
  8. Ureters‏‎ (11:10, 19 December 2021)
  9. Female Pelvis‏‎ (12:17, 19 December 2021)
  10. Epididymis and Vas Deferens‏‎ (12:46, 19 December 2021)
  11. Seminal Vesicles and Ejaculatory Ducts‏‎ (12:48, 19 December 2021)
  12. Candiduria‏‎ (17:57, 21 December 2021)
  13. CUA: Metastatic Castration-naive and Castration-sensitive Prostate Cancer (2020)‏‎ (10:21, 22 March 2022)
  14. CUA: Prostate Cancer Screening (2017)‏‎ (06:48, 23 March 2022)
  15. AUA: Clinically Localized Prostate Cancer (2017)‏‎ (07:29, 23 March 2022)
  16. CUA: RCC Genetic Screening (2013)‏‎ (11:28, 5 April 2022)
  17. Prostate Cancer: Pathology and TNM Staging‏‎ (15:17, 5 April 2022)
  18. Adrenal Insufficiency‏‎ (11:58, 29 September 2022)
  19. Adrenal: Benign Tumours‏‎ (12:23, 29 September 2022)
  20. Retroperitoneal Fibrosis‏‎ (18:46, 30 October 2022)
  21. Genitourinary Complications of Metabolic Syndrome‏‎ (18:50, 30 October 2022)
  22. Renal Hypertension‏‎ (18:56, 30 October 2022)
  23. Renal Transplant‏‎ (19:05, 30 October 2022)
  24. Bladder and Testis Oncology‏‎ (19:16, 30 October 2022)
  25. Pediatrics: Neuromuscular Disorders of the Lower Urinary Tract‏‎ (06:27, 31 October 2022)
  26. Functional: Aging and Geriatric Urology‏‎ (12:10, 4 November 2022)
  27. Infections: Clostridium Difficile Infection‏‎ (12:22, 4 November 2022)
  28. CUA/AUA: Non-muscle Invasive Bladder Cancer (2021 CUA/2016 AUA))‏‎ (05:39, 11 November 2022)
  29. AUA: Surgical Management of LUTS due to BPH (2018)‏‎ (12:11, 11 November 2022)
  30. CUA: Castrate-resistant Prostate Cancer (2021)‏‎ (12:37, 11 November 2022)
  31. CUA: Androgen Deprivation Therapy: Adverse Events & Management (2021)‏‎ (12:38, 11 November 2022)
  32. CUA: Testosterone Suppression (2018)‏‎ (12:39, 11 November 2022)
  33. Cancer Care Ontario: MRI in Prostate Cancer Diagnosis (2017)‏‎ (12:40, 11 November 2022)
  34. CUA: Advanced and Metastatic Urothelial Cancer (2019)‏‎ (12:40, 11 November 2022)
  35. CUA: Prostate Cancer Active Surveillance (2015)‏‎ (12:41, 11 November 2022)
  36. CUA: Asymptomatic Microscopic Hematuria (2008)‏‎ (12:44, 11 November 2022)
  37. CUA: Small Renal Masses (2015)‏‎ (12:46, 11 November 2022)
  38. CUA: Surgical Management of RCC (2014)‏‎ (12:46, 11 November 2022)
  39. CUA: Peyronie's Disease (2018)‏‎ (12:47, 11 November 2022)
  40. CUA: Male LUTS & BPH (2018)‏‎ (12:56, 11 November 2022)
  41. AUA: Prostate Cancer Screening (2018)‏‎ (09:38, 4 January 2023)
  42. Scrotum & Spermatic Cord‏‎ (17:30, 6 January 2023)
  43. Kidneys‏‎ (20:32, 13 January 2023)
  44. Bladder‏‎ (15:57, 19 January 2023)
  45. Orthotopic Urinary Diversion‏‎ (17:35, 24 January 2023)
  46. CUA: Antibiotic Prophylaxis (2015)‏‎ (12:48, 9 February 2023)
  47. CUA: Azoospermia (2015)‏‎ (13:07, 9 February 2023)
  48. CUA: Circumcision (2018)‏‎ (13:11, 9 February 2023)
  49. CUA: Cryptorchidism (2017)‏‎ (13:23, 9 February 2023)
  50. CUA: Multicystic Dysplastic Kidney in the Neonate (2015)‏‎ (13:25, 9 February 2023)

View (previous 50 | ) (20 | 50 | 100 | 250 | 500)